Novo Nordisk now expects 2023 sales growth of between 32% and 38%.
Markets – MarketWatch
Novo Nordisk Raises Sales Outlook on Soaring Demand for Ozempic and Wegovy Markets – MarketWatch
Related Posts
First charter flight for U.S. citizens leaving Israel has taken off, White House says Markets – MarketWatch
The first charter flight that the U.S. State Department is organizing has departed from […]
Avient Lifts Quarterly Dividend by 4% Markets – MarketWatch
By Sabela Ojea Avient raised its quarterly dividend by 4% to nearly 26 cents. […]
US Futures Rise Slightly, European Stocks Mixed Markets – MarketWatch
U.S. futures for the S&P 500 were up 0.1% and futures for the Dow […]